A Tale Of Two Strategies: Genome-Wide Association Study Research On Major Depressive Disorder
Accumulating knowledge about the genetic factors associated with psychiatric illnesses, such as major depressive disorder (MDD), is an important goal of mental health research. By acquiring a comprehensive understanding of their underpinnings, scientists hope to better predict risk, develop more personalized treatments, and increase response and recovery rates for individuals living with serious mental health diagnoses.
One study design being used toward this end is the genome-wide association study (GWAS). GWAS are observational and involve “rapidly scanning markers across the complete …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.